All stock lists
Esco Technologies Inc (New York Stock Exchange:ESE)
US · Delayed Price · Currency is USD
Technology · Hardware, Equipment & Parts
250.59+9.54 (+3.96%)
Market cap
$6.49B
Insider Score
Health Score
Analyst consensus
Listed since
Oct 1, 1990
Website
Insider Score
––Not scored
ESE Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ESE analyst forecast
ESE analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
ESE 12-month price target
No published price targets in the last 12 months.
ESE ratings mix, last 12 months
Buy Hold Sell
Best analysts covering ESE
- Stephens & Co.100%success rate · +47.0% avg return · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ESE analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-10-13 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2026-02-09 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-11-24 |
| — | Benchmark | Buy | — | — | Reiterated | 2025-05-09 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-02-27 |
| — | Benchmark | Buy | — | — | Reiterated | 2025-02-11 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-11-15 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-11-05 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-09-27 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-07-09 |
| — | Sidoti & Co. | Neutral | — | — | Downgraded | 2024-01-05 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-08-28 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2022-11-21 |
| — | Sidoti & Co. | Buy | — | — | Upgraded | 2021-09-28 |
| — | Stephens & Co. | Equal Weight | — | — | Reiterated | 2019-07-09 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2018-08-08 |
| — | B. Riley FBR | Buy | — | — | Reiterated | 2018-08-08 |
| — | Wunderlich | Buy | — | — | Reiterated | 2017-06-13 |
| — | BB&T Capital | Buy | — | — | Reiterated | 2016-05-04 |
| — | Euro Pacific Capital | Buy | — | — | Reiterated | 2015-10-12 |
| — | BB&T Capital | Buy | — | — | Upgraded | 2015-07-13 |
| — | Needham | Hold | — | — | Downgraded | 2013-08-09 |
| — | Baird | Neutral | — | — | Downgraded | 2013-05-08 |
| — | Ardour Capital | Accumulate | — | — | Upgraded | 2013-05-08 |
| — | Oppenheimer | Perform | — | — | Downgraded | 2013-04-18 |
| — | Needham | Buy | — | — | Upgraded | 2013-02-08 |
| — | Pacific Crest | Sector Perform | — | — | Downgraded | 2013-01-31 |
| — | Wedbush | Outperform | — | — | Reiterated | 2013-01-30 |
| — | Canaccord Genuity | Hold | — | — | Reiterated | 2012-11-13 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2012-10-10 |
| — | Ardour Capital | Hold | — | — | Downgraded | 2012-08-10 |
| — | Pacific Crest | Outperform | — | — | Upgraded | 2012-05-10 |
Paid research (issuer-sponsored)
These firms were paid by the company to publish research on it. Their ratings and targets are not counted in the consensus, the price target or the rankings above.
- Fundamental Research Corp · since 2023-02-06
ESE earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-11-20 | 2.13 | 2.32 | $339.1M | $352.7M |
| 2026-02-05 | 1.32 | 1.64 | $279.5M | $289.7M |
| 2026-05-07 | 1.90 | 1.91 | $307.9M | $309.3M |
| 2026-08-06 | 2.12 | 2.20 | $341.4M | $339.0M |
| 2026-11-19Upcoming | 2.60 | — | $375.6M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.